lX International Summit
"Liotta Symposium"
l International Summit
"Argentine Cardiology Federation"
Main office email: summit_hfph@aol.com
Registration email: summit_hfph@aol.com
Web: https://www.heartinnovations.org
Main Office 1: summit_hfph@aol.com
Main Office 2: administration@heartinnovations.org
Phone / Skype 1: +54-9-11-6400 3161
Phone / Skype 2: +1 (737) 529-1345
VI International Heart Failure Summit
Heart Failure and Pulmonary Hypertension Management in the Polypharmacy and Device Era
VIRTUAL CONFERENCE
Heart Failure Review 2021
Liotta Symposium
November 29 - December 04, 2021
New Heart Failure Definition & New Pathophysiologic Pathway
Polypharmacy 1, 2, 3, 4, 5 ,6 …. Therapies in Heart Failure
Cardiometabolic disease and Heart Failure (iSGLT2, GLP-1 agonist)
Cardiomyopathies
Focus in
Amyloidosis. Newer approaches. Early diagnosis and treatment
Devices and remote monitoring for HFREF & HFPEF
Preserved EF HF. Different Phenotypes. Newer therapies.
New Cardiogenic Shock Guidelines
Interventional Heart Failure
Percutaneous Mitral Repair (Focus on Mitraclip)Aortic Stenosis: Low Flow Low gradient Low EF
Arrhythmias Control in Heart Failure
Multimodality imaging in HF.
Hypertrophic Cardiomyopathy (HCOM/HCM)
Pulmonary Hypertension. Different therapeutics approaches. Upfront vs sequential strategy. NOACs
Percutaneous and Durables Ventricular Assist Devices
Total Artificial Heart
Alejandro (Alex) Barbagelata, MD, FAHA, FSCAI, FICA, MSAC
Program Director
Dr. Barbagelata is an invasive cardiologist with Heart Failure longstanding expertise. He was past director of the Heart failure, assist devices and Transplant at University of Texas medical branch. Professor of Medicine/Cardiology Duke University School of Medicine and Board of Directors of DUCCS (Duke University Cardiovascular Society). Member of the International Speaker Bureau of the American Heart Association. He Co-direct the Heart Failure program at the Catholic University and has privileges in several centers in private practice